Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
East Florida Eye Institute (EFEI) is a comprehensive ophthalmology practice and clinical research center based in Stuart, Florida. The institute provides a wide range of specialized eye care services, including advanced cataract surgery, glaucoma management, and vitreoretinal treatments. EFEI is distinguished by its dedicated clinical research department, which participates in multi-center Phase 2, 3, and 4 clinical trials for innovative ophthalmic therapies. The facility serves as a key investigative site for global pharmaceutical and biotechnology companies developing new treatments for macular degeneration, diabetic retinopathy, and dry eye syndrome. Led by Medical Director Dr. Mark J. Michels, the institute integrates state-of-the-art diagnostic technology with a commitment to clinical excellence and scientific advancement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on East Florida Eye Institute.